BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• BioMidwest

  Heathrow Scientific Introduces an Economical 1L Mini Magnetic Stirrer to its Laboratory Equipment Line

  Heathrow Scientific announces the introduction of an economical 1L Mini Magnetic Stirrer to their laboratory equipment line.

  February 7, 2018

   · 

  2 min read
• Pharm Country

  Lannett Voluntarily Pays Down $25M of Term Loans

  Lannett Company today announced that the company voluntarily made a $25M payment against its Term Loans.

  February 7, 2018

   · 

  1 min read
• 

  Drug Development

  On a Roll: FDA Calls Sage’s Depression Drug a Breakthrough

  This is the second Breakthrough Therapy designation granted to Sage since 2016.

  February 7, 2018

   · 

  6 min read
• Time to Elevate Protection in Haemophilia Care: New Data From Sobi

  Sobi will present new evidence at the upcoming 11th Annual Congress of the European Association for Haemophilia and Allied Disorders, in Madrid, Spain, 7-9 February 2018.

  February 7, 2018

   · 

  9 min read
• China Cord Blood Corporation to Change Corporate Name to “Global Cord Blood Corporation”

  The Board believes that the Change of Name better reflects the future development direction and business strategy of the Company.

  February 7, 2018

   · 

  2 min read
• Policy

  Verastem Submits NDA to U.S. FDA for Duvelisib for the Treatment of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma

  In addition, duvelisib received orphan drug designation in the United States and the European Union for patients with CLL, SLL and FL.

  February 7, 2018

   · 

  8 min read
• Appili Therapeutics Raises an Additional $4.3 Million in Oversubscribed Financing to Advance its Anti-infective Pipeline

  Appili Therapeutics today it raised an additional $4,339,000 in an oversubscribed private placement financing, bringing the total equity raised since its seed round in March 2016 to $11,816,000.

  February 7, 2018

   · 

  3 min read
• Business

  Roivant Sciences and ArQule Enter into License Agreement for Derazantinib in China

  Roivant Sciences and ArQule today announced the initiation of a collaboration to pursue the development of derazantinib, a pan-FGFR (fibroblast growth factor receptor) inhibitor, in Greater China.

  February 7, 2018

   · 

  8 min read
• Business

  Pathmaker Neurosystems Awarded Nearly $5M NIH Deal to Develop Myoregulator for the Non-Invasive Treatment of Spasticity

  The 4-year grant has been awarded through the CREATE Devices program that provides a collaborative partnership with the NINDS.

  February 7, 2018

   · 

  3 min read
• Business

  Glaukos Corporation to Release Fourth Quarter and Full Year 2017 Financial Results after Market Close on February 28

  The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PST (4:30 p.m. EST) on February 28, 2018.

  February 7, 2018

   · 

  1 min read